First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
ConclusionsPalliative177Lu-PSMA therapy for salivary gland cancer may lead to rapid relief of tumour-associated discomfort and may even induce disease stabilization. It is safe, relatively well tolerated and can be considered when regular treatment options fail.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Adenocarcinoma | Adenoids | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Pain | Palliative | Prostate Cancer | Radiology | Salivary Gland Cancer | Study | Urology & Nephrology | Xerostomia